Andrew Brunner (@andrewbrunner) 's Twitter Profile
Andrew Brunner

@andrewbrunner

Medical Oncologist specializing in MDS and adult leukemia at Massachusetts General Hospital Cancer Center. Opinions are my own.

ID: 37521520

calendar_today03-05-2009 22:39:03

452 Tweet

589 Followers

393 Following

Andrew Brunner (@andrewbrunner) 's Twitter Profile Photo

This is great. So important to create urban access to nature and this Boston walking path is such a wonderful exploration of both the city and the outdoors

Andrew Brunner (@andrewbrunner) 's Twitter Profile Photo

When we get new molecular or diagnostic tools in MDS it is important to consider how they impact practice today - enjoyed discussing how we are improving MDS risk assessment and with it patient care

Andrew Brunner (@andrewbrunner) 's Twitter Profile Photo

Happy Fourth of July from #Boston And a very merry “running down the middle of storrow drive” day to those who celebrate

Andrew Brunner (@andrewbrunner) 's Twitter Profile Photo

Wish we could get more than top line data from these “all or nothing” releases. Hard to learn if not from our prior work itself

Andrew Brunner (@andrewbrunner) 's Twitter Profile Photo

Everyone values the more efficient mode of travel. The focus should be how to make public transit, biking, walking easier and faster than personal vehicles - particularly in cities

NMDP (@nmdp_org) 's Twitter Profile Photo

Catch up on pt. 2 of our conversation with Zachariah DeFilipp & Dr. Andrew Brunner from Mass General Cancer Center. 🎧 Listen now to discover how to improve #HCT access and #MDS treatment for older patients through shared care: bit.ly/44MlXrG

Catch up on pt. 2 of our conversation with <a href="/DrZackDeFilipp/">Zachariah DeFilipp</a> &amp; Dr. <a href="/andrewbrunner/">Andrew Brunner</a> from <a href="/MGHCancerCenter/">Mass General Cancer Center</a>. 🎧 Listen now to discover how to improve #HCT access and #MDS treatment for older patients through shared care: bit.ly/44MlXrG
Dr. Uma Borate: Associate Professor (@beatalleukemia) 's Twitter Profile Photo

Phase Ib study of sabatolimab (MBG453),targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high & very high‐risk MDS is out! 🙏🏽⁦Andrew Brunner⁩ ⁦David Steensma, MD⁩ & team. Awaiting results of Phase 3 STIMULUS-MDS2 #mdssm onlinelibrary.wiley.com/doi/epdf/10.10…

Andrew Brunner (@andrewbrunner) 's Twitter Profile Photo

Had a great time discussing some of the ongoing challenges in MDS with this esteemed group; hopefully more advances to come in the next year!

Andrew Brunner (@andrewbrunner) 's Twitter Profile Photo

Excited to support Mikkael A. Sekeres MD, MS for ASH Councilor! A reminder if you haven’t submitted your ballot yet for ASH elections you have until September 30! vote.escvote.com/ash